Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Belantamab Mafodotin Combinations for Multiple Myeloma
Recruiting1 awardPhase 2
Indianapolis, Indiana
This trial is studying the side effects of an antibody-drug conjugate called belantamab mafodotin when given with other anti-cancer drugs to people with relapsed or refractory multiple myeloma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service